Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Laura Llauger"'
Autor:
Laura Llauger Bufi, Caterina Torrisi, Christian Steinkühler, Philip Jones, Claudia Giomini, Wu Hao, Sergio Serafini, Alberto Bresciani, Jesus Maria Ontoria Ontoria, Hu Bin, Michael Rowley
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:5274-5282
The Hedgehog (Hh-) signalling pathway is a key developmental pathway and there is a growing body of evidence showing that this pathway is aberrantly reactivated in a number of human tumors. Novel agents capable of inhibiting this pathway are sought,
Autor:
Jesus Maria Ontoria Ontoria, Gabriella Dessole, Massimiliano Fonsi, Michael Rowley, Claudio Giuliano, Edith Monteagudo, Christian Steinkühler, Ester Muraglia, Caterina Torrisi, Maria Cecilia Palumbi, Danila Branca, Philip Jones, Laura Llauger Bufi, Alberto Bresciani
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:5283-5288
Smoothened (Smo) antagonists are emerging as new therapies for the treatment of neoplasias with aberrantly reactivated hedgehog (Hh) signaling pathway. A novel series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as smoothened antago
Autor:
Fabrizio Fiore, Michael Rowley, Philip Jones, Odalys Gonzalez Paz, Massimiliano Fonsi, Edith Monteagudo, Olaf Kinzel, Carsten Schultz-Fademrecht, Christian Steinkühler, Giovanna Pescatore, Laura Llauger-Bufi
Publikováno v:
Journal of Medicinal Chemistry. 52:3453-3456
The optimization of a potent, class I selective ketone HDAC inhibitor is shown. It possesses optimized pharmacokinetic properties in preclinical species, has a clean off-target profile, and is negative in a microbial mutagenicity (Ames) test. In a mo
Autor:
Laura Llauger, Julia Aguirre, Nian Wu, Gabriela Chiosis, Joungnam Kim, Huazhong He, R.M. Immormino, Danuta Zatorska, Daniel T. Gewirth, Yuhong She
Publikováno v:
Journal of Medicinal Chemistry. 49:381-390
Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways. Its inactivation may result in targeting multiple molecular alterations and, thus, in reverting the transformed phenotype. The PU-class, a
Autor:
Gabriela Chiosis, Neal Rosen, Julia Aguirre, Joungnam Kim, Peter Davies, Laura Llauger, Huazhong He, Ulf Peters
Publikováno v:
Journal of Medicinal Chemistry. 48:2892-2905
Hsp90 is a chaperone protein with important roles in maintaining transformation and in elevating the survival and growth potential of cancer cells. Currently there is an increasing interest in developing inhibitors of this protein as anticancer thera
Publikováno v:
Tetrahedron Letters. 40:3961-3964
The addition of a series of stabilized carbon nucleophiles to 3-acyl-1-alkylpyridinium salts. followed by acylation of the intermediate dihydropyridines with trichloroacetic anhydride has been studied. The C-4 adducts resulting from the addition of
Publikováno v:
Organic Letters. 4:3083-3085
[reaction: see text] Efficient photodecarboxylation of (3-benzoylphenyl)alkanoic acids with formation of carbanions has enabled the determination of their protonation rate constants in water; the values obtained show that the reactivity toward proton
Publikováno v:
ChemInform. 30
The addition of a series of stabilized carbon nucleophiles to 3-acyl-1-alkylpyridinium salts. followed by acylation of the intermediate dihydropyridines with trichloroacetic anhydride has been studied. The C-4 adducts resulting from the addition of
Autor:
Samuele Lillini, Carsten Schultz-Fademrecht, Edith Monteagudo, Carlo Toniatti, Ester Muraglia, Olaf Kinzel, Caterina Torrisi, Danila Branca, Laura Llauger Bufi, Federica Ferrigno, Michael Rowley, Philip Jones
Publikováno v:
Bioorganicmedicinal chemistry letters. 20(3)
We describe an extensive SAR study in the 6-[4-fluoro-3-(substituted)benzyl]-4,5-dimethylpyridazin-3(2H)-one series which led to the identification of potent PARP-1 inhibitors, capable of inhibiting the proliferation of BRCA-1 deficient cancer cells
Autor:
Carlo Toniatti, Fabrizio Fiore, Philip Jones, Laura Llauger Bufi, Danila Branca, Olaf Kinzel, Michael Rowley, Giovanna Pescatore, Caterina Torrisi, Ester Muraglia, Federica Orvieto
Publikováno v:
Bioorganicmedicinal chemistry letters. 20(3)
Herein we describe the discovery of a novel series of pyrrolo[1,2-a]pyrazin-1(2H)-one PARP inhibitors. Optimization led to compounds that display excellent PARP-1 enzyme potency and inhibit the proliferation of BRCA deficient cells in the low double-